🇺🇸 FDA
Pipeline program

Terlipressin treatment

2019ZDSYLL196-P01

Unknown small_molecule completed

Quick answer

Terlipressin treatment for Septic Shock is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Septic Shock
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials